Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania

Abstract
Rifampin or multidrug-resistant tuberculosis (RR/MDR-TB) treatment has largely transitioned to regimens free of the injectable aminoglycoside component, despite the drug class’ purported bactericidal activity early in treatment. We tested whether Mycobacterium tuberculosis
Funding Information
  • DELTAS Africa Initiative (Afrique One-ASPIRE /DEL-15-008)
  • DELTA Africa Initiative (Afrique One-ASPIRE /DEL-15-008)
  • DELTA Africa Initiative (Afrique One-ASPIRE /DEL-15-008)
  • European and Developing Countries Clinical Trials Partnership (TMA2016SF-1463-REMODELTZ)
  • European and Developing Countries Clinical Trials Partnership (TMA2016SF-1463-REMODELTZ)